Dr. Warren Viricel, our company’s Chief Scientific Officer, is invited to present Mablink’s PSARlink™ drug-linker technology at the 12th annual PEGS Europe Virtual summit (Lisbon, PT) on Tuesday, November 10, 2020.
He discusses our latest developments on 3rd generation ADCs in a presentation called “Monodisperse Polysarcosine Drug-Linker Platform: Towards More Hydrophilic Antibody-Drug Conjugates”.
About PEGS Europe Virtual: PEGS Europe Summit is the largest European event covering all aspects of protein and antibody engineering. This year’s distinguished faculty includes 260 speakers from more than 20 countries including nearly 70% from Europe. 64% work at a Pharma/Biotech organization, and 26% are in Academia. To learn more about what leading scientists are reporting from the front lines of cutting-edge engineering and therapeutics, please visit PEGS Europe website here.